Scopus Biopharma Stock Market Value
| SCPS Stock | USD 0.0004 0.0002 33.33% |
| Symbol | Scopus |
Scopus Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scopus Biopharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scopus Biopharma.
| 12/03/2025 |
| 01/02/2026 |
If you would invest 0.00 in Scopus Biopharma on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Scopus Biopharma or generate 0.0% return on investment in Scopus Biopharma over 30 days. Scopus Biopharma is related to or competes with Orphazyme A/S. Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics t... More
Scopus Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scopus Biopharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scopus Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1132 | |||
| Maximum Drawdown | 303.33 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 33.33 |
Scopus Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scopus Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scopus Biopharma's standard deviation. In reality, there are many statistical measures that can use Scopus Biopharma historical prices to predict the future Scopus Biopharma's volatility.| Risk Adjusted Performance | 0.0909 | |||
| Jensen Alpha | 3.94 | |||
| Total Risk Alpha | 1.51 | |||
| Treynor Ratio | (1.14) |
Scopus Biopharma Backtested Returns
Scopus Biopharma is out of control given 3 months investment horizon. Scopus Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-three different technical indicators, which can help you to evaluate if expected returns of 3.97% are justified by taking the suggested risk. Use Scopus Biopharma Variance of 1086.2, risk adjusted performance of 0.0909, and Coefficient Of Variation of 870.08 to evaluate company specific risk that cannot be diversified away. Scopus Biopharma holds a performance score of 9 on a scale of zero to a hundred. The entity has a beta of -3.3, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Scopus Biopharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Scopus Biopharma is expected to outperform it. Use Scopus Biopharma treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to analyze future returns on Scopus Biopharma.
Auto-correlation | 0.00 |
No correlation between past and present
Scopus Biopharma has no correlation between past and present. Overlapping area represents the amount of predictability between Scopus Biopharma time series from 3rd of December 2025 to 18th of December 2025 and 18th of December 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scopus Biopharma price movement. The serial correlation of 0.0 indicates that just 0.0% of current Scopus Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Scopus Biopharma lagged returns against current returns
Autocorrelation, which is Scopus Biopharma otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Scopus Biopharma's otc stock expected returns. We can calculate the autocorrelation of Scopus Biopharma returns to help us make a trade decision. For example, suppose you find that Scopus Biopharma has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Scopus Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Scopus Biopharma otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Scopus Biopharma otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Scopus Biopharma otc stock over time.
Current vs Lagged Prices |
| Timeline |
Scopus Biopharma Lagged Returns
When evaluating Scopus Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Scopus Biopharma otc stock have on its future price. Scopus Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Scopus Biopharma autocorrelation shows the relationship between Scopus Biopharma otc stock current value and its past values and can show if there is a momentum factor associated with investing in Scopus Biopharma.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Scopus OTC Stock Analysis
When running Scopus Biopharma's price analysis, check to measure Scopus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scopus Biopharma is operating at the current time. Most of Scopus Biopharma's value examination focuses on studying past and present price action to predict the probability of Scopus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scopus Biopharma's price. Additionally, you may evaluate how the addition of Scopus Biopharma to your portfolios can decrease your overall portfolio volatility.